Loading…
Envista Holdings Corporation is projected to rise to $27.06 by 2027, a +16% move from its current price of $23.31. NVST is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $22.92 | $23.32 | $23.73 | +0.05% |
| May 30 | $22.77 | $23.33 | $23.91 | +0.10% |
| May 31 | $22.66 | $23.35 | $24.05 | +0.15% |
| Jun 1 | $22.57 | $23.36 | $24.18 | +0.20% |
| Jun 2 | $22.49 | $23.37 | $24.29 | +0.25% |
| Jun 3 | $22.41 | $23.38 | $24.39 | +0.31% |
| Jun 4 | $22.35 | $23.39 | $24.48 | +0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $22.35 | $23.39 | $24.48 | +0.36% |
| Week 2 | $22.01 | $23.48 | $25.04 | +0.72% |
| Week 3 | $21.77 | $23.56 | $25.50 | +1.08% |
| Week 4 | $21.58 | $23.64 | $25.90 | +1.44% |
| Week 5 | $21.43 | $23.73 | $26.28 | +1.80% |
| Week 6 | $21.30 | $23.81 | $26.63 | +2.16% |
| Week 7 | $21.18 | $23.90 | $26.96 | +2.53% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Envista Holdings Corporation, incorporated in 2018 and headquartered in Brea, California, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables, serving oral surgeons, prosthodontists, and general dentists with a range of products and services. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics, along with brackets, wires, clear aligners, digital orthodontic treatments, and related laboratory products, under brands such as Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, and AOA.
The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, endodontic systems, restorative materials, bonding agents, cements, and infection prevention products, offered under Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals.
Envista Holdings Corporation (NVST) is a healthcare/dental products company with two operating segments: Specialty Products & Technologies and Equipment & Consumables. The current price is $23.43, and the company has a market capitalization of $3.81B, ranking 1543 by market cap. The stock’s outlook, based on the provided forecasts, shows a path of gradual to substantial upside over the coming years, culminating in a much higher average price by 2050.
The long-term forecast highlights bullish momentum with very large potential upside relative to today’s price, though near-term action remains more muted. Current technicals place the name in a neutral to cautiously constructive setting, with finite upside and defined resistance levels ahead.
A major floor 14.5% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.1% away) — a key level to hold.
The nearest ceiling, 19.5% above — a clean break opens room to run.
A major ceiling 29.8% above — clearing it would confirm fresh momentum.
Key NVST support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NVST market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $23.53 | Sell | $23.45 | Sell |
| MA 10 | $23.48 | Sell | $23.69 | Sell |
| MA 20 | $24.45 | Sell | $24.31 | Sell |
| MA 50 | $25.53 | Sell | $25.17 | Sell |
| MA 100 | $25.79 | Sell | $24.93 | Sell |
| MA 200 | $23.22 | Buy | $23.67 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 35.62 | Neutral |
| Stoch RSI (14) | 66.03 | Neutral |
| CCI (20) | -72.58 | Neutral |
| Williams %R (14) | -79.03 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | -3.84 | Sell |
| Bollinger %B (20,2) | 0.27 | Neutral |
| Stochastic %K (14) | 20.97 | Neutral |
| TRIX (15) | -0.42 | Sell |
| Awesome (5,34) | -1.99 | Sell |
| Ultimate (7,14,28) | 39.51 | Neutral |
| Momentum (10) | -0.97 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 23.50 | Sell |
| ADX (14) | 22.97 | Sell |
| ATR (14) | 0.36 | Info |
The 30-day technical picture is NEUTRAL with RSI(14) at 40, indicating modest momentum and no overbought conditions. The stock trades with a SMA50 of $25.59 and a SMA200 of $23.18, suggesting price action around the longer-term trend. Immediate support sits at $23.05 and resistance at $27.85, framing a 30-day range of $20.78 to $26.42.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $21.69 | $23.31 | $29.08 | 0% | Neutral | |
| $22.11 | $27.06 | $34.67 | +16% | Neutral | |
| $22.77 | $28.39 | $37.32 | +22% | Bullish | |
| $23.24 | $29.41 | $39.47 | +26% | Bullish | |
| $26.78 | $34.33 | $46.89 | +47% | Bullish | |
| $30.79 | $39.96 | $55.42 | +71% | Bullish | |
| $34.34 | $45.06 | $63.39 | +93% | Bullish | |
| $35.98 | $47.70 | $67.96 | +105% | Bullish | |
| $35.76 | $47.88 | $69.03 | +105% | Bullish | |
| $38.00 | $51.36 | $74.86 | +120% | Bullish | |
| $56.73 | $79.96 | $122.09 | +243% | Bullish | |
| $99.64 | $150.59 | $246.41 | +546% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $21.69 | $23.31 | $27.33 | +0.00% |
| June 2026 | $20.64 | $24.08 | $28.64 | +3.31% |
| July 2026 | $20.81 | $24.42 | $29.31 | +1.40% |
| August 2026 | $20.34 | $23.97 | $28.98 | -1.83% |
| September 2026 | $20.22 | $23.92 | $29.09 | -0.21% |
| October 2026 | $20.43 | $24.25 | $29.66 | +1.40% |
| November 2026 | $20.12 | $23.95 | $29.43 | -1.25% |
| December 2026 | $19.73 | $23.56 | $29.08 | -1.63% |
Click any year to see its month-by-month NVST forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, NVST is projected to trade between $21.69 and $29.08, averaging $23.31 — a potential gain of 0% from today's $23.31. Price action looks broadly range-bound.
Envista Holdings Corporation's 2027 outlook centres on $27.06, within a $22.11 to $34.67 range. That is up +16% on the projected 2026 average. That marks a +16% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, NVST could reach as high as $37.32, with a base case around $28.39 and support toward $22.77 — roughly +22% from $23.31. Momentum favours further upside here.
Expect NVST to range from $23.24 to $39.47 through 2029. The $29.41 average target implies a +26% move from current prices. That is up +4% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The NVST price prediction for 2030 points to an average of $34.33 (low $26.78, high $46.89) — a potential gain of +47% on today's $23.31. Momentum favours further upside here.
In 2031, NVST is projected to trade between $30.79 and $55.42, averaging $39.96 — a potential gain of +71% from today's $23.31. That is up +16% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Envista Holdings Corporation's 2032 outlook centres on $45.06, within a $34.34 to $63.39 range. That is up +13% on the projected 2031 average. That marks a +93% change versus current levels. Momentum favours further upside here.
By 2033, NVST could reach as high as $67.96, with a base case around $47.70 and support toward $35.98 — roughly +105% from $23.31. Buyers look set to stay in control over this stretch.
Expect NVST to range from $35.76 to $69.03 through 2034. The $47.88 average target implies a +105% move from current prices. That is up 0% on the projected 2033 average. Momentum favours further upside here.
The NVST price prediction for 2035 points to an average of $51.36 (low $38.00, high $74.86) — a potential gain of +120% on today's $23.31. Buyers look set to stay in control over this stretch.
In 2040, NVST is projected to trade between $56.73 and $122.09, averaging $79.96 — a potential gain of +243% from today's $23.31. That is up +56% on the projected 2035 average. Momentum favours further upside here.
Envista Holdings Corporation's 2050 outlook centres on $150.59, within a $99.64 to $246.41 range. That is up +88% on the projected 2040 average. That marks a +546% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in NVST today (≈ 42.900043 NVST) could be worth
$6,460.46
+$5,460.46 (+546%) by 2050 · US Dollar
Based on the average projected NVST price of $150.59 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NVSTwould be worth at today's price.
$1,000 invested in NVST on May 27, 2025 (≈ 55.555556 NVST) would be worth
$1,295
+$295 (+29.5%) today · 1.29× · US Dollar
Based on a NVST entry price of $18 vs. today's $23.31.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $23.77 | $980.65 | -1.9% |
| 1 month ago | $26.77 | $870.75 | -12.9% |
| 3 months ago | $29.3 | $795.56 | -20.4% |
| 6 months ago | $20.9 | $1,115.31 | +11.5% |
| 1 year ago | $18 | $1,295 | +29.5% |
| All time (5.0y) ago | $42.92 | $543.1 | -45.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NVST forecast.
Our base-case forecast reaches $47.00 around 2033.
Implied market cap at $47.00: $7.65B
The year-by-year forecast shows a steady lift from 2026 onward. The 2026 forecast has an avg of $23.43 with a min of $21.69 and a max of $29.44 (ROI 0, sentiment NEUTRAL). By 2027 the avg rises to $27.76 (min $22.67, max $35.58) with ROI 18.5 (sentiment NEUTRAL), and by 2028 the avg reaches $29.17 (min $23.40, max $38.36) with ROI 24.5 (BULLISH).
The trajectory continues higher through 2029 (avg $30.56, min $24.14, max $41.02; ROI 30.4; BULLISH) and 2030 (avg $36.36, min $28.35, max $49.67; ROI 55.2; BULLISH). Beyond 2030, forecasts remain bullish with notable steps: 2031 avg $42.28 (ROI 80.4), 2032 avg $47.82 (ROI 104.1), 2033 avg $50.98 (ROI 117.6), 2034 avg $51.05 (ROI 117.9), 2035 avg $55.41 (ROI 136.5). The long-horizon view shows substantial upside: 2040 avg $86.92 (ROI 271) and 2050 avg $168.23 (ROI 618), both with BULLISH sentiment.
These figures reflect estimates and are not guarantees, with risks and uncertainties inherent in long-range price forecasting.
Tap a question to reveal the answer.
2030 forecast: avg $36.36, min $28.35, max $49.67; ROI 55.2; sentiment BULLISH.
From 2027 onward the forecast shows rising averages and bullish sentiment, with 2027 avg $27.76 and 2030 avg $36.36, plus large long-term upside (2031+ and beyond). ROI figures progress from 18.5 in 2027 to 55.2 in 2030 and 618 in 2050, though these are estimates, not guarantees.
The 2040 forecast shows min $61.66, avg $86.92, max $132.73 with ROI 271; since the max exceeds $100, a $100 target lies within the predicted range, but these are estimates rather than guaranteed outcomes.
The 30-day picture is NEUTRAL with RSI(14) at 40. It trades with SMA50 at $25.59 and SMA200 at $23.18, with support at $23.05 and resistance at $27.85, within a 30-day range of $20.78 to $26.42.
For 2050 the forecast shows avg $168.23, min $111.30, max $275.29 with ROI 618 and sentiment BULLISH.
Envista Holdings Corporation Community Discussion
0Share your Envista Holdings Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.